Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Titel:
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Auteur:
Bennouna, Jaafar Bompas, Emmanuelle Neidhardt, Eve Marie Rolland, Frédéric Philip, Irène Galéa, Céline Salot, Samuel Saiagh, Soraya Audrain, Marie Rimbert, Marie Lafaye-de Micheaux, Sylvie Tiollier, Jérôme Négrier, Sylvie